Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Aim: Due to altered red blood cell survival and erythropoietin therapy glycated haemoglobin (HbA1c) may not accurately reflect long‐term glycaemic control in patients with diabetes and chronic kidney disease (CKD). Glycated albumin (GA) and fructosamine are alternative markers of glycaemia. The aim of this study was to investigate the accuracy of HbA1c, GA and fructosamine as indicators of glycaemic control using continuous glucose monitoring. Methods: HbA1c, GA and fructosamine concentrations were measured in 25 subjects with diabetic nephropathy (CKD stages 4 and 5 (estimated glomerular filtration rate <30 mL/min per 1.73 m 2)) matched with 25 subjects with diabetes and no evidence of nephropathy. Simultaneous real‐time glucose concentrations were monitored by continuous glucose monitoring over 48 h. Results: GA correlated significantly to mean glucose concentrations in patients with and without CKD (r = 0.54 vs 0.49, P < 0.05). A similar relationship was observed with fructosamine relative to glucose. A poor correlation between HbA1c and glucose was observed with CKD (r = 0.38, P = ns) but was significant in the non‐CKD group (r = 0.66, P < 0.001). The GA/HbA1c ratio was significantly higher in diabetic patients with CKD compared with controls (2.5 ± 0.4 vs 2.2 ± 0.4, P < 0.05). HbA1c values were significantly lower in CKD patients, relative to non‐CKD patients at comparable mean glucose concentrations. Conclusion: HbA1c significantly underestimates glycaemic control in patients with diabetes and CKD stages 4 and 5. In severe CKD, GA more accurately reflects glycaemic control compared with fructosamine and HbA1c and should be the preferred marker of glycaemic control.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.12.005 · Cited by 1,788
Relationship between glycated haemoglobin levels and mean glucose levels over time
Nathan, D. M., Turgeon, H., & Regan, S. (2007) · Diabetologia · doi:10.1007/s00125-007-0803-0 · Cited by 517
Tahara, Y., & Shima, K. (1995) · Diabetes Care · doi:10.2337/diacare.18.4.440 · Cited by 380
Comparison of glycated albumin and hemoglobin A1c levels in diabetic subjects on hemodialysis
Peacock, T. P., Shihabi, Z. K., Bleyer, A. J., Dolbare, E. L., Byers, J. R., Knovich, M. A., Calles-Escandon, J., Russell, G. B., & Freedman, B. I. (2008) · Kidney International · doi:10.1038/ki.2008.25 · Cited by 323 · cited 2×
“Albumin is glycated in a similar manner as haemoglobin,(35) but is not affected by RBC lifespan, or ESA administration.(20,21) As such, GA is suggested to be a more appropriate measure of glycaemic control as well as a predictor of developing vascular complications in CKD due to diabetes.”
BackgroundChico, A., Vidal-Ríos, P., Subirà, M., & Novials, A. (2003) · Diabetes Care · doi:10.2337/diacare.26.4.1153 · Cited by 235
Freedman, B. I., Shenoy, R. N., Planer, J. A., Clay, K. D., Shihabi, Z. K., Burkart, J. M., Cardona, C. Y., Andries, L., Peacock, T. P., Sabio, H., et al. (2010) · Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis · doi:10.3747/pdi.2008.00243 · Cited by 121 · cited 1×
“A tendency to lower GA values in a PD group has been demonstrated, although no significant differences in the accuracy of GA as an index of glycaemia was detected.(19) The present study included predialysis, HD and PD subjects, a representation of the usual CKD population seen in clinical practice.”
Result
Cited by
KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease
Rossing, P., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Khunti, K., Liew, A., Michos, E. D., Navaneethan, S. D., Olowu, W. A., et al. (2022) · Kidney International · doi:10.1016/j.kint.2022.06.008 · Cited by 1,373
Positioning time in range in diabetes management
Advani, A. (2020) · Diabetologia · doi:10.1007/s00125-019-05027-0 · Cited by 170
Update on biomarkers of glycemic control
Krhač, M., & Lovrenčić, M. V. (2019) · World Journal of Diabetes · doi:10.4239/wjd.v10.i1.1 · Cited by 93
Zelnick, L. R., Batacchi, Z. O., Ahmad, I., Dighe, A., Little, R. R., Trence, D. L., Hirsch, I. B., & de Boer, I. H. (2020) · Diabetes Care · doi:10.2337/dc20-0915 · Cited by 55
Jung, M., Warren, B., Grams, M., Kwong, Y. D., Shafi, T., Coresh, J., Rebholz, C. M., & Selvin, E. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12618 · Cited by 43
Metadata
- Authors
- VOS, F. E., SCHOLLUM, J. B., COULTER, C. V., MANNING, P. J., DUFFULL, S. B., & WALKER, R. J.
- Venue
- Nephrology
- Publisher
- Wiley
- Published
- 2012-01-19
- Volume
- 17
- Issue
- 2
- Pages
- 182-188
- ISSN
- 1320-5358 (ISSN-L)
- 1440-1797
- OpenAlex
- W1895654641
- Cited by
- 115
- References
- 6
- FWCI
- 6.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring. https://app.cochat.ai/papers/10.1111/j.1440-1797.2011.01517.x
- The paper
- VOS, F. E., SCHOLLUM, J. B., COULTER, C. V., MANNING, P. J., DUFFULL, S. B., & WALKER, R. J. (2012). Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring. Nephrology. https://doi.org/10.1111/j.1440-1797.2011.01517.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.